Percutaneous closure of patent ductus arteriosus with the Nit-Occlud patent ductus arteriosus device in 268 consecutive cases.

Background: The pfm Nit-Occlud patent ductus arteriosus (PDA) device is well established for interventional closure of PDA. However, there are still limited data concerning its efficacy and follow-up in larger patient groups.

Aims: This study aimed to evaluate the safety and efficacy of the Nit-Occlud PDA device, implanted both through transpulmonary and transaortic approach, in a large cohort.